Pages that link to "Q28475651"
Jump to navigation
Jump to search
The following pages link to Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use (Q28475651):
Displaying 50 items.
- Viral Evolution and Escape during Acute HIV‐1 Infection (Q24600713) (← links)
- Viral quasispecies evolution (Q27013917) (← links)
- Drug-class specific impact of antivirals on the reproductive capacity of HIV (Q28473451) (← links)
- Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study (Q28474221) (← links)
- Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing (Q28474783) (← links)
- The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach (Q28476558) (← links)
- Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects (Q28478134) (← links)
- Minor HIV-1 variants with the K103N resistance mutation during intermittent efavirenz-containing antiretroviral therapy and virological failure (Q28478779) (← links)
- Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing (Q28480762) (← links)
- The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients (Q28535577) (← links)
- Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure (Q28539186) (← links)
- Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China (Q28539368) (← links)
- Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy (Q28541754) (← links)
- HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China (Q28550283) (← links)
- Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission (Q28550310) (← links)
- Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART (Q28552784) (← links)
- An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies (Q28554999) (← links)
- Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data (Q28727944) (← links)
- Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection (Q30407004) (← links)
- Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing (Q30499244) (← links)
- Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies (Q33645217) (← links)
- Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models (Q33741902) (← links)
- Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city (Q33827257) (← links)
- Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation (Q33974966) (← links)
- Minority variants of drug-resistant HIV. (Q34047780) (← links)
- A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1. (Q34062608) (← links)
- Comparison of methods to detect HIV dual infection (Q34447788) (← links)
- Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing (Q34567556) (← links)
- Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques (Q34742502) (← links)
- Directly Observed Antiretroviral Therapy in Substance Abusers Receiving Methadone Maintenance Therapy Does Not Cause Increased Drug Resistance (Q34875358) (← links)
- Detection of cytomegalovirus drug resistance mutations by next-generation sequencing (Q34975934) (← links)
- Within-host nucleotide diversity of virus populations: insights from next-generation sequencing (Q35047735) (← links)
- Clinical management of HIV drug resistance (Q35261045) (← links)
- Applications of next-generation sequencing technologies to diagnostic virology (Q35600172) (← links)
- Switching between raltegravir resistance pathways analyzed by deep sequencing (Q36011436) (← links)
- Decoding the evolution of a breast cancer genome (Q36039142) (← links)
- Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection (Q36551179) (← links)
- Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory (Q36667504) (← links)
- Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. (Q36690550) (← links)
- Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment. (Q36745453) (← links)
- Clinical implications of HIV-1 minority variants (Q36811249) (← links)
- Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach (Q37285249) (← links)
- Next generation DNA sequencing and the future of genomic medicine (Q37651413) (← links)
- Low-abundance resistant mutations in HIV-1 subtype C antiretroviral therapy-naive individuals as revealed by pyrosequencing. (Q37734688) (← links)
- HIV Type-1 Drug Resistance in Treatment-Naive Patients Monitored Using Minority Species Assays: A Systematic Review and Meta-Analysis (Q37839548) (← links)
- Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology (Q37985256) (← links)
- Benchmarking of viral haplotype reconstruction programmes: an overview of the capacities and limitations of currently available programmes (Q38068990) (← links)
- Recent advances in research of HIV infection: implications of viral and host genetics on treatment and prevention. (Q38095239) (← links)
- Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance (Q38413362) (← links)
- Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples. (Q38738833) (← links)